The effect of Allopurinol in prevention of contrast induced nephropathy in patients undergoing angioplasty

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190406043182N1

Enrollment

100

Registered

2019-10-05

Start date

2019-04-17

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephropathy. Disorder of kidney and ureter, unspecified

Interventions

Intervention 1: Use of Allopurinol. Intervention 2: Use of Placebo.

Eligibility

Sex/Gender

All

Age

55 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusion criteria: 1. Age> 55,2. The first turn of angioplasty3. Elective angioplasty4. Creatinine> 1 mg / kg5. Normal GFR Out put

Exclusion criteria

Exclusion criteria: Exclusion criteria:1. Emergency Angioplasty,2. Diabetes3. History of the ARF4. Chronic renal failure5. Family history of kidney disease

Design outcomes

Primary

Measure	Time frame
GFR. Timepoint: before-after. Method of measurement: Urinary albumin level was measured by an electroanalytical analyzer, which was measured automatically by spectrophotometric method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHaleh Bodagh

Tabriz University of Medical Sciences

haleh.bodagh@gmail.com+98 41 3389 3710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026